Выпуск
Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million
Pharmaceutical Executive · 5 ноября 2026 г. · 2 мин
ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTransporter deal with BioArctic 14 months after signing, and Ignite Proteomics’ Dr. Brian Corgiat on improving how tumors are tested after recurrence.